The Angiogenic Balance and Its Implications in Cancer and Cardiovascular Diseases: An Overview

Medicina (Kaunas). 2022 Jul 6;58(7):903. doi: 10.3390/medicina58070903.

Abstract

Angiogenesis is the process of developing new blood vessels from pre-existing ones. This review summarizes the main features of physiological and pathological angiogenesis and those of angiogenesis activation and inhibition. In healthy adults, angiogenesis is absent apart from its involvement in female reproductive functions and tissue regeneration. Angiogenesis is a complex process regulated by the action of specific activators and inhibitors. In certain diseases, modulating the angiogenic balance can be a therapeutic route, either by inhibiting angiogenesis (for example in the case of tumor angiogenesis), or by trying to activate the process of new blood vessels formation, which is the goal in case of cardiac or peripheral ischemia.

Keywords: activators; angiogenesis; cancer; cardiovascular diseases; inhibitors.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Cardiovascular Diseases* / drug therapy
  • Female
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Neovascularization, Pathologic / drug therapy

Substances

  • Angiogenesis Inhibitors

Grants and funding

This research received no external funding.